These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2634703)

  • 21. Antihypertensive effect of oral timolol maleate and hydrochlorothiazide once daily compared with hydrochlorothiazide once daily.
    Durley Y; Cubberley RB; Thomas S
    Am J Hosp Pharm; 1981 Aug; 38(8):1161-4. PubMed ID: 7270561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of ambulatory registration of arterial pressure in therapeutic trials of antihypertensive agents].
    Rion F; Waeber B; Graf HJ; Jaussi A; Porchet M; Brunner HR
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1829-31. PubMed ID: 4089582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined action of enalapril or timolol with hydrochlorothiazide plus amiloride in hypertension.
    Lumme JA; Jounela AJ
    Ann Clin Res; 1987; 19(5):344-50. PubMed ID: 2831788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
    Sjöberg KH
    Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of propranolol in permanent essential hypertension].
    Safar M; Weiss Y; Simon A; Lehner JP; Milliez P
    Ann Med Interne (Paris); 1975 Nov; 126(11):737-43. PubMed ID: 1211699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of propranolol in essential hypertension--results of a 10-year therapeutic course study].
    Dück KD; Knappe J
    Z Gesamte Inn Med; 1983 Dec; 38(23):640-4. PubMed ID: 6670340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timolol/bendrofluazide combination ('Prestim') in the treatment of poorly controlled hypertensive patients in general practice.
    Douglas-Jones AP
    Pharmatherapeutica; 1984; 3(9):631-5. PubMed ID: 6728865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of trial therapy on subsequent therapy. A review of patients with hypertension who have completed a pharmacological intervention study.
    Carney SL; Gillies AH; Smith AJ; Floate LF
    Med J Aust; 1986 Mar; 144(6):315-6. PubMed ID: 3520265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antihypertensive effects of timolol and of the combination timolol, amiloride and hydrochlorothiazide].
    Cospite M; Ferrara F; Raimondi F; Lo Presti T; Ballo M; Milio G; Meli F
    Clin Ter; 1981 Sep; 98(6):617-26. PubMed ID: 7026143
    [No Abstract]   [Full Text] [Related]  

  • 36. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a fixed ratio combination of hydrochlorothiazide, amiloride and timolol ('Moducren') given once versus twice daily in mild to moderate hypertension.
    Young JH; VandenBurg MJ; Isitt VL; Currie WJ
    Pharmatherapeutica; 1984; 4(1):64-8. PubMed ID: 6504947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of beta adrenergic blocking agents (alprenolol and propranolol) in essential hypertension.
    Nik-Akhtar B; Rashed MA; Khakpour M
    Angiology; 1975 Apr; 26(4):339-43. PubMed ID: 1119734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propranolol as an antihypertensive agent in children.
    Griswold WR; McNeal R; Mendoza SA; Sellers BB; Higgins S
    Arch Dis Child; 1978 Jul; 53(7):594-6. PubMed ID: 686799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic, reflexive, and metabolic alterations induced by acute and chronic timolol therapy in hypertensive man.
    Dunn FG; de Carvalho JG; Frohlich ED
    Circulation; 1978 Jan; 57(1):140-4. PubMed ID: 618381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.